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Therole of government in health care has expandedover the years and influenced political discourseandpolicy.Whether this is an appropriate role has
een contested. Still, the government, with extensive pro-
rams and market influence, is likely to play a major role
n achieving better quality and value in health care and in
he success or failure of lasting healthcare reform. This
aper attempts to describe current efforts of the govern-
ent to improve quality and value in the healthcare sys-
em by discussing the Affordable Care Act (ACA) of 2010
nd various “drivers” the government uses.
The U.S. spends more per capita on health care than
ny other nation in the world.1 Yet the measured out-
comes of the care provided are no better than, and are
often inferior to, outcomes achieved by other developed
nations that spend substantially less (Organization for
Economic Co-operation and Development).1 Moreover,
best-practices guidelines for healthcare delivery are not
followed routinely, and wide geographic variations exist
in healthcare costs and quality.2 Healthcare costs have
increased over the past 3 decades and consume an in-
creasing share of the U.S. Gross Domestic Product
(GDP), now accounting for a greater percentage of GDP
than any other sector of the U.S. economy.
Federal leadership has been stimulated anew under the
ACA and numerous other pieces of recent healthcare
legislation. As a result, the role of government in the U.S.
healthcare system is being contested more than ever.
Several studies have researched the role government can
play in the management of healthcare costs and have
presented several arguments. Although views on the
value and appropriateness of government involvement
may differ, there is consensus that government is a major
stakeholder in combating rising healthcare costs.
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The federal government has played a major role in health
care over the past half century from the establishment of
Medicare andMedicaid in 1965—ensuring access to insur-
ance coverage for a large portion of the U.S. population—
to multiple pieces of legislation from the 1980s to early
2000s that protect individuals under employer-
sponsored health insurance and expanded federal
healthcare programs. Federal government influence
has resulted in public programs that, in 2008, led to
expenditures of $1.11 trillion.3 Further, the laws, reg-
lations, policies, payment systems, and oversight of
hese huge federal programs have major direct and
ndirect influences on private-sector payers and the
ealth care that is delivered to Americans not covered
nder federal programs.
Because of its influence, the government has played an
mportant role in promoting the use of preventive ser-
ices. It also has promoted increased recognition of how
isease prevention contributes to healthcare effıciency
nd cost-savings. Originally, Medicare was not allowed
o authorize primary preventive services. Specifıcally,
screening tests” were expressly excluded as a benefıt
nder Medicare, and that general exclusion continues to
he present day. It was not until 1980 that the U.S. Con-
ress authorized the fırst specifıc prevention screening
enefıt for Medicare benefıciaries. Since that time, Con-
ress has added separately benefıt status to some preven-
ive services as recommended by various bodies respon-
ible for preventive services guidelines.
More recently, under Section 101 of the Medicare &
edicaid Improvements for Patients and Providers Act
MIPPA) of 2008, Congress authorized the Secretary of
HHS to add additional preventive services to theMedi-
are benefıt structure via the National Coverage Decision
NCD) process of the Centers for Medicare & Medicaid
ervices (CMS). This is a major advance in facilitating
revention benefıts and coverage in the Medicare pro-
ram, albeit with limitations. BecauseMedicare decision-
aking with respect to what services are/are not covered
nfluences Medicaid, its Children’s Health Insurance
rogram (CHIP), and private-sector payers, it presents












S40 Straube / Am J Prev Med 2013;44(1S1):S39–S42an important opportunity for federal healthcare policy to
promote preventive services as necessary for optimal in-
dividual healthcare delivery and address public health
issues.
The Affordable Care Act and Preventive
Health Care
The most recent, and potentially most influential, federal
healthcare legislation is the ACA. It illustrates how fed-
eral legislation can address the inadequacies of current
federal healthcare efforts by promoting greater emphasis
on disease prevention and health promotion as essential
building blocks of overall healthcare reform, improving
health outcomes, and reducing healthcare costs. The
ACA is divided into 10major titles. One of them, Title IV:
Prevention of Chronic Disease and Improvement of Pub-
lic Health, is devoted entirely to prevention issues and ini-
tiatives. Prominent subtopics addressed in this legislation
include modernizing disease prevention and public health
systems, increasing access to clinical and community-based
preventive services, launching education andoutreach cam-
paigns regarding the benefıts and use of preventive services,
providing support for prevention and public health innova-
tion, and supporting wellness programs.
Title IV, Subtitle A, Section 4001, directed the Presi-
dent to establish, within DHHS, the National Prevention,
Health Promotion and Public Health Council. In addi-
tion to having presidential oversight, the council includes
members from a comprehensive list of government agen-
cies. Chaired by the Surgeon General of the U.S., the
council is perhaps the highest-level and broadest admin-
istrative group in the Executive Branch, save the Cabinet.
On June 16, 2011, the council issued a 125-page report
titled “National Prevention Strategy.” Its vision was
“working together to improve the health and quality of
life for individuals, families, and communities bymoving
the nation from a focus on sickness and disease to one
based on prevention and wellness.” Its overarching goal
was to “increase the number of Americans who are
healthy at every stage of life.”
The report set four strategic directions: building
healthy and safe community environments, expanding
quality preventive services in clinical and community
settings, empowering people to make healthy choices,
and eliminating health disparities. Its seven targeted pri-
orities were tobacco-free living, prevention of drug/alco-
hol abuse, healthy eating, active living, injury/violence-
free living, reproductive/sexual health, and mental/
emotional well-being. For each of the directions and
priorities, the report made multiple specifıc, evidence-
based recommendations.In addition, the report detailed specifıc actions to which
the federal government would commit and outlined
evidence-basedactions thatpartners, businesses, employers,
healthcare systems, insurers, clinicians, educational organi-
zations, community/nonprofıt/faith-based organizations,
individuals, and families could implement to comple-
ment federal activities. The report also stressed the col-
laborative nature of priority setting and the importance of
continuing that collaborative process involving all
healthcare stakeholders in goal setting, design, imple-
mentation, and accountability. The Agency for Health-
care Research and Quality (AHRQ) was designated the
lead, with assistance of other DHHS agencies, to develop
more-specifıc details for the plan.
Just a few months before the council’s report was is-
sued, DHHS submitted its own report, the “National
Strategy for Quality Improvement in Health Care,” to
Congress in March 2011.4 The six national priorities
dentifıed were making care safer by reducing harm
aused in the delivery of care; ensuring that each person
and family) is engaged as a partner(s) in patient care;
romoting effective communication and coordination
f care; promoting the most effective prevention and
reatment practices for the leading causes of mortality;
orking with communities to promote the use of best
ractices to enable healthy living; and making high-
uality care more affordable for individuals, families,
mployers, and governments by developing and spr-
ading new healthcare-delivery models.
The Affordable Care Act and the Barrier of
Cost-Sharing
The ACA included recognition that recommended
preventive services are used at levels far below desired
utilization. Cost-sharing for these services by patients,
including copayments, co-insurance, and deductibles,
was cited as a barrier to achieving desired rates. Subse-
quent to ACA requirements, a regulation was issued
jointly by DHHS, the Department of Labor, and the
Department of the Treasury requiring health plans to
cover a prescribed list of recommended evidence-
based preventive services and eliminate cost-sharing as
of September 23, 2010. The list of covered services
spans routine adult services; a comprehensive list of
children’s services/screenings/counseling; women’s
and infant’s services; and a number of disease-specifıc
services for cardiac disease, obesity, cancer, diabetes,
and other chronic illnesses. The legislation facilitates
additions to the list, as evidence becomes available that
confırms the effıcacy of such services.
www.ajpmonline.org
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JThe Centers for Medicare & Medicaid
Services’ Role in Improving Healthcare
Quality and Value
Beyond the ACA, federal healthcare agencies, particu-
larly CMS, have long had statutory authority to effect
change in the U.S. healthcare system. This authority,
when used effectively, wields a great deal of power to
address defıciencies in the quality and value of health care
provided to the public. This authority extends beyond
federal healthcare programs to affect the private sector,
including providers, payers, and health plans; state and
local government; pharmaceutical and device manufac-
turers; other suppliers; and myriad other categories of
healthcare stakeholders.
The Centers for Medicare & Medicaid Services as a
prototype, for example, can apply various drivers, alone
or in combination, that have power to catalyze and
hasten prevention efforts, improve patient-centered
outcomes, and maximize value in the U.S. healthcare
system. These drivers are available at the federal and
state level, are arguably not used to their maximum
effect, and are also variably applicable to private com-
mercial healthcare-sector payers, employers, inte-
grated health systems, healthcare collaboratives, and
other healthcare stakeholders.
These drivers emphasize traditional quality im-
provement but with evidence-based interventions and
accountability for improved outcomes that can be at-
tributed to the funding and interventions claimed to
cause the change. But they also can be used to imple-
ment many recommendations of the “National Pre-
vention Strategy.” Traditionally, CMS has relied on its
Quality Improvement Organization (QIO) Program
and End-Stage Renal Disease (ESRD) Network Pro-
gram to target improvements in healthcare quality, but
there are many examples of broader collaborations and
efforts outside these formal programs that the federal
government could lead.
Other Federal Drivers of Prevention
Increased Healthcare System Transparency
Increased healthcare system transparency is beginning to
take place through public reporting and Internet-based
dissemination of healthcare data (predicated on wide-
spread adoption and “meaningful use” of health informa-
tion technology). Currently, a number of preventive ser-
vices and health promotionmetrics are reported publicly
via a variety of CMS and DHHS websites, most notably
the CMS “Compare” websites. These websites report
provider-level process and outcomes, and continue to
grow in terms of the amount of data they contain.
anuary 2013This information can be used for a variety of purposes.
Applications include monitoring progress toward goals,
setting benchmarks, allowing consumers to choose pro-
viders or sites of care, assisting payers in rewarding better
quality and value, and aiding policymakers and research-
ers in their work. Increasing the number of prevention/
wellness measures and settings measured (e.g., informa-
tion on states, communities, organizations, and systems)
is needed to implement theNational Prevention Strategy.
Payment System Incentives
Another driver is alignment of healthcare reimburse-
ment with better quality and value. Vehicles for achiev-
ing this goal include value-based purchasing (VBP);
pay-for-performance (P4P); withholding penalties; gain-
sharing; accountable care organizations (ACOs); and
medical homes.
Strategic Use of Regulation
Regulation, as a driver, includes setting quality standards
and processes through conditions of participation (CoPs)
or conditions for coverage (CfCs) and ensuring compli-
ance. All DHHS agencies and many other federal agen-
cies produce regulations that can motivate/require better
prevention and health promotion.
Evidence-Based Decision Making
Evidence-based decision making, as a driver, must be
supported by increased comparative-effectiveness re-
search and cost-effective analysis. Using research results
from these types of studies, the federal coverage process
can try to balance promotion of technology innovation
with avoidance of wasteful/unnecessary technology (and
unproven technology); treatments; pharmaceuticals; de-
vices; and medical services, including those relating to
preventive and wellness services.
Conclusion
The federal role in health care has expanded over the
years. It is likely to play a major role in achieving better
quality and value in health care and the success or failure
of healthcare reformmore generally. The U.S. healthcare
system, as a major segment of the U.S. economy, faces
serious challenges that threaten its output and viability.
Chronic disease is a major contributor to healthcare ex-
penditures and, although prevention and health promo-
tion efforts have not been optimal, they can play an im-
portant role in improving health outcomes.
Many evidence-based prevention interventions and ini-
tiatives have been identifıed, but progress has eluded the
country as a whole. Federal leadership has been stimulated
under the ACA of 2010 and numerous other pieces of
23
S42 Straube / Am J Prev Med 2013;44(1S1):S39–S42healthcare legislation that provide powerful “drivers” of
healthcare quality and value improvement, particularly for
prevention and health promotion efforts. Whether or not
federal efforts will succeed is arguable, but without them
national progress seems unlikely.
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Did you know?
According to the 2012 Journal Citation Report,
published by Thomson Reuters, the 2011 impact
factor for AJPM is 4.044, which ranks it in the
top 8% of PH and OEP journals, and in the
top 11% of GM and IM journals.www.ajpmonline.org
